JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
GEN
3976
DELISTED
Genesis Healthcare, Inc.
GEN
| $265K | ﹤0.01% |
313,899
-73,922
| -19% | -$106K |
2016 Q4
13 quarters
|
|
|
ADAP
3977
DELISTED
Adaptimmune Therapeutics
ADAP
| $264K | ﹤0.01% |
96,737
+20,531
| +27% | +$68.1K |
2016 Q3
14 quarters
|
|
3978
iShares MSCI France ETF
EWQ
$334M
| $264K | ﹤0.01% |
+11,246
| New | +$329K |
2020 Q1
0 quarters
|
|
3979
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$41.3B
| $263K | ﹤0.01% |
10,997
-55,315
| -83% | -$1.58M |
2015 Q4
17 quarters
|
|
3980
DMC Global
BOOM
$120M
| $262K | ﹤0.01% |
11,391
+2,616
| +30% | +$94.1K |
2017 Q4
9 quarters
|
|
3981
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36B
| $260K | ﹤0.01% |
10,044
+3,853
| +62% | +$123K |
2019 Q4
1 quarter
|
|
|
NVRO
3982
CALL
DELISTED
NEVRO CORP.
NVRO
| $260K | ﹤0.01% |
+2,600
| New | +$313K |
2020 Q1
0 quarters
|
|
|
FARO
3983
DELISTED
Faro Technologies
FARO
| $258K | ﹤0.01% |
5,786
+190
| +3% | +$9.85K |
2016 Q1
16 quarters
|
|
3984
FVCBankcorp
FVCB
$319M
| $258K | ﹤0.01% |
24,200
-2,283
| -9% | -$28.3K |
2018 Q4
5 quarters
|
|
|
CRC
3985
DELISTED
California Resources Corporation
CRC
| $258K | ﹤0.01% |
257,786
+36,211
| +16% | +$224K |
2014 Q4
21 quarters
|
|
|
GLOG
3986
PUT
DELISTED
GASLOG LTD
GLOG
| $257K | ﹤0.01% |
+71,000
| New | +$433K |
2020 Q1
0 quarters
|
|
3987
Natural Gas Services Group
NGS
$433M
| $255K | ﹤0.01% |
57,164
-32,064
| -36% | -$301K |
2016 Q4
13 quarters
|
|
3988
Invesco DB US Dollar Index Bullish Fund
UUP
$441M
| $254K | ﹤0.01% |
9,456
+9,169
| +3,195% | +$244K |
2014 Q4
21 quarters
|
|
3989
Fulcrum Therapeutics
FULC
$283M
| $253K | ﹤0.01% |
21,176
+15,264
| +258% | +$244K |
2019 Q3
2 quarters
|
|
3990
Ovid Therapeutics
OVID
$457M
| $253K | ﹤0.01% |
84,853
-134,876
| -61% | -$455K |
2017 Q4
9 quarters
|
|
3991
Armstrong World Industries
AWI
$6.91B
| $252K | ﹤0.01% |
3,167
-1,590
| -33% | -$153K |
2015 Q1
20 quarters
|
|
3992
CALL
Datadog
DDOG
$99.3B
| $252K | ﹤0.01% |
+7,000
| New | +$289K |
2020 Q1
0 quarters
|
|
3993
State Street SPDR S&P Telecom ETF
XTL
$554M
| $251K | ﹤0.01% |
4,247
+28
| +0.7% | +$1.87K |
2016 Q1
16 quarters
|
|
|
SBT
3994
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $251K | ﹤0.01% |
58,415
-2,801
| -5% | -$18.2K |
2018 Q1
8 quarters
|
|
3995
Aterian
ATER
$11.4M
| $250K | ﹤0.01% |
+12,782
| New | +$628K |
2020 Q1
0 quarters
|
|
3996
Evolution Petroleum
EPM
$143M
| $250K | ﹤0.01% |
95,640
-180,500
| -65% | -$818K |
2017 Q3
10 quarters
|
|
|
LGF.A
3997
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $250K | ﹤0.01% |
41,145
-1,072
| -3% | -$9.56K |
2016 Q4
13 quarters
|
|
3998
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$414M
| $249K | ﹤0.01% |
6,094
| – | – |
2013 Q3
26 quarters
|
|
|
LOTZW
3999
DELISTED
CarLotz, Inc. Warrant
LOTZW
| – | – |
0
| – | – |
2019 Q4
1 quarter
|
|
|
RLH
4000
DELISTED
Red Lions Hotel Corporation
RLH
| $249K | ﹤0.01% |
171,147
-260,026
| -60% | -$696K |
2017 Q4
9 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.